News
ANVISA approves 3 new Galileo kits for anti-SARS-CoV-2 antibodies (COVID-19)
20 de February de 2021
Galileo Biotech went through the extensive and rigorous approval process of its products for the detection of anti-IgM, IgG and IgM+IgG antibodies by ELISA for SARS-CoV-2. Kits